The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called ...

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain. This marks the first approval of a new class of pain relief drugs in more than 20 ...

The St. Clair County Drug Tactical Unit raided a Belleville ... She also teaches journalism at St. Louis Community College at Forest Park. She holds degrees from Southern Illinois University ...

A drug dealer who made £210,000 from selling kilo quantities of cocaine has been ordered to pay back just £17,000. He was found in possession of thousands of pounds worth of designer clothes ...

35,009 people played the daily Crossword recently. Can you solve it faster than others?35,009 people played the daily Crossword recently. Can you solve it faster than others?

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...